The DRUGMATRIX assay aims to inhibit the Carbonic Anhydrase II enzyme by using 4-Nitrophenyl acetate (4-NPA) as the substrate. It exclusively targets a single protein and is assigned as such. The assay uses Erythrocyte cells from the Homo sapiens organism and is conducted in vitro. The type of assay is described as Binding. Does this molecule show effectiveness in this assay?